Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Filings indexed 659 across all filing types
Latest filing 2024-09-16 Regulatory Filings
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2024-09-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing Profound Medical's participation in an upcoming investor conference. It contains no financial data, no report or filing, and no regulatory or voting information. It is a brief corporate announcement about a management event (participation in a conference). The document length is short (3098 characters), and it does not mention any report being attached or published. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2024-09-04 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-08-08 English
Interim MD&A - English.pdf
Regulatory Filings
2024-08-08 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-08-08 English
News release - English.pdf
Regulatory Filings
2024-08-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.